Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis
Part of paid clinical trials in New York, New York.
- Sponsor
- Weill Medical College of Cornell University
- Study ID
- NCT07746427
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - 17 Years
- Healthy Volunteers
- Not accepted
Interventions
- Digital App Mindfulness Meditation — BEHAVIORALRegular use of a digital mindfulness meditation app 3-4 times per week for 10-15 minutes each session.
- Mindfulness Meditation Sheet — BEHAVIORALParticipants will read an informational handout on mindfulness meditation at the start of the study.
Study Details
Atopic dermatitis is well reported to have a significant impact on well-being in adolescents with atopic dermatitis, without clear recommendations for intervention. The investigators aim to identify an accessible, effective digital health intervention for these patients. The investigators hypothesize that regular use of a digital mindfulness meditation app will improve disease control and quality of life in adolescents with moderate to severe atopic dermatitis based on validated survey measures.
Key Dates
- First listed
- Aug 5, 2026
- Start date
- Aug 15, 2026
- Status verified
- Jul 2026
- Primary completion
- Jul 31, 2028
- Completion
- Jul 31, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Mindfulness Meditation via Digital AppParticipants will use of a mindfulness meditation digital app.
- Active Comparator: Mindfulness Meditation SheetParticipants will read an information sheet on mindfulness meditation.
Primary Outcome Measure
Mean Atopic Dermatitis Control Tool (ADCT) score. [ Time Frame: Pre and post 1 month study observation period. ]
Central Contacts
- Dana A O'Toole, MD646-962-3410
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Columbia University Irving Medical Center | New York | New York | 10036 | Melissa Stockwell, MD PMH (PRINCIPAL_INVESTIGATOR) |
| Weill Cornell Medicine | New York | New York | 10021 | Dana O'Toole, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
Nationwide
By condition
By specialty
Related Studies
- Skin Microbial Ecology in Atopic DermatitisRecruiting · University of Rochester · Rochester, New York
- A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their OffspringRecruiting · Pfizer · New York, New York
- A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic DermatitisPHASE2 · Recruiting · Pfizer · Birmingham, Alabama
- A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabPHASE3 · Recruiting · AbbVie · Birmingham, Alabama